Compound, material for forming underlayer film for lithography, underlayer film for lithography and pattern forming method
US-2015376202-A1 · Dec 31, 2015 · US
US9389183B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9389183-B2 |
| Application number | US-201313793517-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 11, 2013 |
| Priority date | Jan 24, 2008 |
| Publication date | Jul 12, 2016 |
| Grant date | Jul 12, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure is directed to fluorogenic schiff base-forming dyes capable of detecting analytes containing aldehyde and ketone groups. The dyes contain nucleophilic hydrazinyl appendages and are capable of binding and detecting analytes in situ.
Opening claim text (preview).
The invention claimed is: 1. A hydrazinyl-substituted compound of Formula I: or a stereoisomer, tautomer, hydrate, solvate, or salt thereof; wherein, X is H or an analyte selected from the group consisting of an amino acid, a peptide, a protein, a carbohydrate, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid polymer, a drug, a lipid, a synthetic polymer, malondialdehyde, and 4-hydroxynonenal; R 1 is selected from the group consisting of H, alkyl and substituted alkyl; R 1a is H; R 2 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are each independently selected from the group consisting of H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, aminosulfonylamino, amidino, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, halo, hydroxy, nitro, SO 3 − , sulfonyl, substituted sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, substituted alkylthio, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl; and R 3 is selected from the group consisting of alkoxy, substituted alkoxy, amino, substituted amino, hydrazinyl, substituted hydrazinyl, analyte substituted hydrazinyl, alkyl, substituted alkyl, acyl, acylamino, acyloxy, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, aminosulfonylamino, amidino, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, halo, hydroxy, nitro, SO 3 − , sulfonyl, substituted sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, substituted alkylthio, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl; or R 2 and R 3 , R 3 and R 4 , or R 2 , R 3 and R 4 are taken together to form a fused heterocyclyl group, a fused substituted heterocyclyl group, a fused aryl group, a fused substituted aryl group, a fused heteroaryl group or a fused substituted heteroaryl group. 2. The compound of claim 1 , wherein R 2 , R 3 and R 4 are taken together to form a fused heterocyclyl group or substituted fused heterocyclyl group of the formula: and R 12 and R 13 are each independently selected from the group consisting of H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, aminosulfonylamino, amidino, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, halo, hydroxy, nitro, SO 3 − , sulfonyl, substituted sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, substituted alkylthio, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl. 3. The compound of claim 1 , wherein X is H. 4. The compound of claim 1 , wherein X is an analyte. 5. The compound of claim 4 , wherein the analyte is bound through an imine. 6. The compound of claim 4 , wherein the analyte comprises an aldehyde group. 7. The compound of claim 1 , wherein R 3 is analyte substituted hydrazinyl. 8. The compound of claim 7 , wherein the analyte of R 3 is bound through an imine. 9. The compound of claim 7 , wherein the analyte of R 3 is selected from the group consisting of an amino acid, a peptide, a protein, a carbohydrate, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid polymer, a drug, a lipid, and a synthetic polymer. 10. The compound of claim 7 , wherein the analyte of R 3 comprises a carbonyl group or an aldehyde group. 11. A compound selected from the group consisting of: 12. A method for determining the presence of an analyte of interest in a sample, wherein the analyte of interest is selected from the group consisting of an amino acid, a peptide, a protein, a carbohydrate, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid polymer, a drug, a lipid, a synthetic polymer, malondialdehyde, and 4-hydroxynonenal, wherein the method comprises: contacting the sample with a compound having Formula I: or a stereoisomer, tautomer, hydrate, solvate, or salt thereof; wherein, X is H; R 1 is selected from the group consisting of H, alkyl and substituted alkyl; R 1a is H; R 2 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are each independently selected from the group consisting of H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, aminosulfonylamino, amidino, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, halo, hydroxy, nitro, SO 3 − ,sulfonyl, substituted sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, substituted alkylthio, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl; R 3 is selected from the group consisting of alkoxy, substituted alkoxy, amino, substituted amino, hydrazinyl, alkyl, substituted alkyl, acyl, acylamino, acyloxy, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, aminosulfonylamino, amidino, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, halo, hydroxy, nitro, SO 3 − , sulfonyl, substituted sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, substituted alkylthio, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl; or R 2 and R 3 , R 3 and R 4 , or R 2 , R 3 and R 4 are taken together to form a fused heterocyclyl group, a fused substituted heterocyclyl group, a fused aryl group, a fused substituted aryl group, a fused heteroaryl group or a fused substituted heteroaryl group; incubating the sample and the compound for a sufficient amount of time to form a complex between the compound and analyte; illuminating the complex with an appropriate wavelength to form an illuminated complex; and detecting emissions from the illuminated complex. 13. The method of claim 12 , wherein the analyte and the compound are connected by a covalent bond. 14. The method of claim 13 , wherein the analyte is bound to the compound through an imine. 15. The method of claim 12 , wherein the compound becomes fluorescent after formation of the complex. 16. The method of claim 12 , wherein the analyte comprises an aldehyde group. 17. The method of claim 12 , wherein the sample comprises live ce
containing organic luminescent materials · CPC title
Aromatic phosphonium compounds (P-C aromatic linkage) · CPC title
Xanthenes · CPC title
Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)} · CPC title
Non-macromolecular compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.